Skip to main content
SpringerLink
Log in

Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer

  • Published:
Cell Biophysics Aims and scope Submit manuscript

Abstract

Local administration of radioimmunoconjugates may allow successful tumor therapy. Bladder cancer appears well suited to this approach, because of its superficial and multifocal nature, and because it will allow direct intravesical administration of conjugates. Implantation of human bladder cancer cell lines in the bladder wall of nude rats results in tumor formation, providing an excellent model to test this. We have developed two murine monoclonal antibodies (MAbs), BLCA-8, IgG3, and BLCA-38, IgG1, both of which react with malignant cells and shed into voided urine of patients with transitional cell carcinoma (TCC) of the bladder, but not with normal bladder urothelial cells. Radioimmunoconjugates produced with131Iodine (131I) or125I have been used for biodistribution studies following administration directly into the bladder. Radioiodinated intact MAbs or Fabs administered intravesically into nontumor-bearing rats did not leak into the systemic circulation and were stable in urine for up to 100h. Biodistribution studies carried out following intraperitoneal or intravesical administration of radioimmunoconjugates to tumor-bearing nude rats indicate good tumor uptake of both MAbs. Together with immunoreactivity assays, these studies demonstrate that131I-labeled MAbs have considerable potential for intravesical radioimmunotherapy of human bladder tumors, and further studies are under way.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Silverberg E., Boring C. C., and Squires T. S. (1990)Cancer Statistics,40, 9–26.

    CAS  Google Scholar 

  2. Raghavan D., Shipley W. U., Garnick M. B., Russell, P. J., and Richie, J. P. (1990) Biology and management of bladder cancer: advances and innovations.N. Engl. J. Med. 322, 1129–1138.

    Article  PubMed  CAS  Google Scholar 

  3. Bander N. H. (1987) Monoclonal antibodies in urologic oncology.Cancer 60, 658–667.

    Article  PubMed  CAS  Google Scholar 

  4. Dotsikas G., Konowalchuk T., Major P. P., Kovac, P. E., Ward, G. K., Stewart, S. S., Price, G. B., Elhilali, M. M., and Mackillop, W. J. (1987) Cellular heterogeneity in normal and neoplastic human urothelium: a study using murine monoclonal antibodies.Br. J. Cancer 56, 439–444.

    PubMed  CAS  Google Scholar 

  5. Russell, P. J., Ho Shon, I., Boniface, G. R., Bard, M. E., Philips, J., Raghavan, D., and Walker, K. Z. (1991) Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. A model for intravesical immunotherapy.Urol. Res. 19, 207–213.

    Article  PubMed  CAS  Google Scholar 

  6. Walker K. Z., Russell P. J., Kingsley E. A., Philips, J., and Raghavan, D. (1989) Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay.J. Urol. 142, 1578–1583.

    PubMed  CAS  Google Scholar 

  7. Lightfoot, D. V., Walker, K. K., Boniface, G. R., Hetherington, E. L., Izard, M. E., and Russell, P. J. (1991) Dosimetric and therapeutic studies in nude mice xenograft models with153Samarium-labeled monoclonal antibody, BLCA-38.Antibody Immunoconjugates and Radiopharmaceuticals 4, 319–330.

    Google Scholar 

  8. Russell, P. J., Jelbart, M., Wills, E. J., Singh, S., Wass, J., Wotherspoon, J., and Raghavan, D. (1988) Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation.Int. J. Cancer 41, 74–82.

    Article  PubMed  CAS  Google Scholar 

  9. Brown, J., Russell, P. J., Philips, J., Wotherspoon, J., and Raghavan, D. (1990) Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity.Br. J. Cancer 61, 369–376.

    PubMed  CAS  Google Scholar 

  10. Chen, T. R. (1977)In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.Exp. Cell Res. 104, 255–262.

    Article  PubMed  CAS  Google Scholar 

  11. Russell P. J., Raghavan D., Gregory P., Philips, J., Wills, E. J., Jelbart, M., Wass, J., Zbroja, R., and Vincent, P. C. (1986) Bladder cancer xenografts: a model of tumor cell heterogeneity.Cancer Res. 46, 2035–2040.

    PubMed  CAS  Google Scholar 

  12. Russell, P. J., Boniface, G. R., Izard, M. E., Lightfoot, D. V., Gansow, O., Brechbiel, M., Raghavan, D., and Walker, K. Z. (1990) Development of animal models to assess radioimmunoconjugates for the treatment of bladder cancer. Proceedings of International Conference on Treatment of Melanoma and Other Cancers, Sept. 1990, Newcastle, NSW.

  13. Britton, W. J., Hellquist, L., Basten, A., and Raison, R. L. (1985)M. leprae antigens involved in human immune responses.J. Immunol. 135, 4171–4177.

    PubMed  CAS  Google Scholar 

  14. Walker K. Z., Seymour-Munn K., and Keech F. K. (1986) A rat model system for radioimmunodetection ofkappa myeloma antigen on malignant B cells.Eur. J. Nucl. Med. 12, 461–467.

    Article  PubMed  CAS  Google Scholar 

  15. Brechbiel, M. W. and Gansow, O. A. (1991) Backbone-substituted DTPA ligands for90Y radioimmunotherapy.Bioconjugate Chem. 2, 187–194.

    Article  CAS  Google Scholar 

  16. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A. (1984) Determination of immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.J. Immunol. Meth. 72, 77–79.

    Article  CAS  Google Scholar 

  17. Goldenberg, D. (1988) Targeting of cancer with radiolabeled antibodies: prospects for imaging and therapy.Arch. Pathol. Lab. Med. 112, 580–586.

    PubMed  CAS  Google Scholar 

  18. Riva, P., Marangolo, S., Lazzari, M., Agostini, M., Sarti, G., Moscatelli, G., Franceschi, G., Spinelli, A., and Vechhietti, G. (1989) Locoregional immunotherapy of human ovarian cancer: preliminary results.Nucl. Med. Biol. 16, 659–666.

    CAS  Google Scholar 

  19. Boekmann, W., Baum, R. P., Schuldes, H., Kramer, W., Hertel, A., Baew-Christow, T., Hanke, P., Jonas, D., and Hor, G. (1990) Tumour imaging of bladder carcinomas and their metastases with111indium-labelled monoclonal anti-CEA antibody BW 431/26.Br. J. Cancer 62, Suppl. X, 81–84.

    Google Scholar 

  20. Epenetos, A. A., Snook., D., Durbin, H., Johnson, P. M., and Papdimitriou, J. (1986) Limitations of monoclonal antibodies for localization of human neoplasms.Cancer Res. 46, 3183–3191.

    PubMed  CAS  Google Scholar 

  21. Colcher, D., Esteban, J., Carrasquillo, J. A., Sugarbaker, P., Reynolds, J. C., Bryant, G., Larson, S. M., and Schlom, J. (1987) Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.Cancer Res. 47, 4218–4224.

    PubMed  CAS  Google Scholar 

  22. Epenetos, A. A., Munro, A. J., Stewart, S., Rampling, R., Lambert, H. G., McKenzie, C. G., Soutler, P., Rachemtulla, A., Hooker, G., Sivolapenka, G. B., Snook, D., Courtney-Luck, N., Dhokia, B., Krausz, T., Taylor-Papadimitriou, J., and Bodmer, W. F. (1987) Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.J. Clin. Oncol. 5, 1890–1899.

    PubMed  CAS  Google Scholar 

  23. Hnatowich, D. J., Chinol, M., Siebecker, D. A., Gionet, M., Griffin, T., Doherty, P. W., Hunter, R., and Kase, K. R. (1988) Patient biodistribution of intraperitoneally administered Yttrium-90-labeled antibody.J. Nucl. Med. 29, 1428–1434.

    PubMed  CAS  Google Scholar 

  24. Wahl, R. L. and Liebert, M. (1989) Improved radiolabeled monoclonal antibody uptake by lavage of intraperitoneal carcinomatosis in mice.J. Nucl. Med. 30, 60–65.

    PubMed  CAS  Google Scholar 

  25. Griffin, T. W., Collins, J., Bokhari, F., Stochl, M., Brill, A. B., Ito, T., Emond, G., and Sando, H. (1990) Intraperitoneal immunoconjugates.Cancer Res. 50, 1031–1038.

    Google Scholar 

  26. Newling, D. (1990) Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU group.Br. J. Cancer 61, 497–499.

    PubMed  CAS  Google Scholar 

  27. Bamias A., Keane, P., Krausz, T., Williams G., and Epenetos, A. A. (1991). Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma.Cancer Res. 51, 724–728.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncology Research Centre, Prince of Wales Hospital, 2031, Sydney

    P. J. Russell

  2. Kanematsu Laboratories, Royal Prince Alfred Hospital, 2050, Sydney

    J. Plomley & I. Ho Shon

  3. Department of Clinical Immunology, Royal Prince Alfred Hospital, 2050, Sydney

    H. O’Grady

  4. Centenary Institute for Cancer Medicine and Cell Biology, 2006, Sydney, Australia

    I. Ho Shon & N. Pearce

Authors
  1. P. J. Russell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Plomley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Ho Shon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. O’Grady
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Pearce
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russell, P.J., Plomley, J., Shon, I.H. et al. Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer. Cell Biophysics 22, 27–47 (1993). https://doi.org/10.1007/BF03033865

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033865

Index Entries

Search

Navigation